BioInfra Life Science (XKRX:266470) Gross-Profit-to-Asset % : 25.18% (As of Dec. 2023)

View and export this data going back to 2020. Start your Free Trial

What is BioInfra Life Science Gross-Profit-to-Asset %?

Gross-Profit-to-Asset % is calculated as Gross Profit divided by its average Total Assets over a certain period of time. BioInfra Life Science's annualized Gross Profit for the quarter that ended in Dec. 2023 was ₩946 Mil. BioInfra Life Science's average Total Assets over the quarter that ended in Dec. 2023 was ₩3,758 Mil. Therefore, BioInfra Life Science's annualized Gross-Profit-to-Asset % for the quarter that ended in Dec. 2023 was 25.18%.

BioInfra Life Science Gross-Profit-to-Asset % Historical Data

The historical data trend for BioInfra Life Science's Gross-Profit-to-Asset % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

BioInfra Life Science Gross-Profit-to-Asset % Chart

BioInfra Life Science Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Gross-Profit-to-Asset %

Get a 7-Day Free Trial

10.34

5.28

14.95

17.97

25.18

BioInfra Life Science Semi-Annual Data
	Dec16	Dec17	Dec18	Dec19	Dec20	Dec21	Dec22	Dec23
Gross-Profit-to-Asset %	Get a 7-Day Free Trial			10.34	5.28	14.95	17.97	25.18

Competitive Comparison of BioInfra Life Science's Gross-Profit-to-Asset %

For the Biotechnology subindustry, BioInfra Life Science's Gross-Profit-to-Asset %, along with its competitors' market caps and Gross-Profit-to-Asset % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

BioInfra Life Science's Gross-Profit-to-Asset % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, BioInfra Life Science's Gross-Profit-to-Asset % distribution charts can be found below:

* The bar in red indicates where BioInfra Life Science's Gross-Profit-to-Asset % falls into.

BioInfra Life Science Gross-Profit-to-Asset % Calculation

BioInfra Life Science's annualized Gross-Profit-to-Asset % for the fiscal year that ended in Dec. 2023 is calculated as:

Gross-Profit-to-Asset %	=	Gross Profit (A: Dec. 2023 )	/	( (Total Assets (A: Dec. 2022 )	+	Total Assets (A: Dec. 2023 ))	/ count )
	=	946.168	/	( (4912.778	+	2602.454)	/ 2 )
	=	946.168	/	3757.616
	=	25.18 %

BioInfra Life Science's annualized Gross-Profit-to-Asset % for the quarter that ended in Dec. 2023 is calculated as:

Gross-Profit-to-Asset %	=	Gross Profit (Q: Dec. 2023 )	/	( (Total Assets (Q: Dec. 2022 )	+	Total Assets (Q: Dec. 2023 ))	/ count )
	=	946.168	/	( (4912.778	+	2602.454)	/ 2 )
	=	946.168	/	3757.616
	=	25.18 %

In the calculation of annual Gross-Profit-to-Asset %, the Gross Profit of the last fiscal year and the average total assets over the fiscal year are used. In calculating the quarterly data, the Gross Profit data used here is one times the annual (Dec. 2023) data. Gross-Profit-to-Asset % is displayed in the 30-year financial page.

BioInfra Life Science Gross-Profit-to-Asset % Related Terms

Thank you for viewing the detailed overview of BioInfra Life Science's Gross-Profit-to-Asset % provided by GuruFocus.com. Please click on the following links to see related term pages.

BioInfra Life Science Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » BioInfra Life Science Inc (XKRX:266470) » Definitions » Gross-Profit-to-Asset %

Comparable Companies

Traded in Other Exchanges

N/A

Address

Daehak-ro 49, 7th Floor, Jongno-gu, Seoul, KOR, 03127

Website

http://www.bioinfra.co.kr

BioInfra Life Science Inc is a bio-technology company engaged in developing cancer gene treatments and technologies that systematically monitor the possibility of metastasis and recurrence in blood for cancer patients.

BioInfra Life Science Headlines

No Headlines